Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccinationPascal Irrgang, Matthias Tenbusch, Antonia Sophia Peter et al.|Science Immunology|2022Cited by 280
Heterologous prime–boost vaccination with ChAdOx1 nCoV-19 and BNT162b2Matthias Tenbusch, Monika Wytopil, Sofie Schumacher et al.|The Lancet Infectious Diseases|2021Cited by 133
Reactogenicity Correlates Only Weakly with Humoral Immunogenicity after COVID-19 Vaccination with BNT162b2 mRNA (Comirnaty®)Jürgen Held, Christian Bogdan, Jan Esse et al.|Vaccines|2021Cited by 41
Dynamics of humoral and cellular immune responses after homologous and heterologous SARS-CoV-2 vaccination with ChAdOx1 nCoV-19 and BNT162b2Emanuel Vogel, Matthias Tenbusch, Katharina Kocher et al.|EBioMedicine|2022Cited by 30
Class switch towards non-inflammatory IgG isotypes after repeated SARS-CoV-2 mRNA vaccinationPascal Irrgang, Matthias Tenbusch, Juliane Gerling et al.|medRxiv|2022Cited by 9